0001237899-13-000077.txt : 20131220
0001237899-13-000077.hdr.sgml : 20131220
20131220175433
ACCESSION NUMBER: 0001237899-13-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131218
FILED AS OF DATE: 20131220
DATE AS OF CHANGE: 20131220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 131292678
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-12-18
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001377247
Powchik Peter
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Clinical Development & Reg
Common Stock
2013-12-18
4
S
0
9000.0
270.2
D
20742
D
Common Stock
2013-12-18
4
M
0
295.0
21.25
A
21037
D
Common Stock
2013-12-18
4
F
0
23.0
264.86
D
21014
D
Common Stock
2013-12-18
4
F
0
139.0
264.86
D
20875
D
Common Stock
2013-12-20
4
S
0
133.0
271.09
D
20742
D
Common Stock
1589
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
21.25
2013-12-18
4
M
0
295.0
0.0
D
2019-12-18
Common Stock
295
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 9,000 shares of Company stock on December 18, 2013 at prices ranging from $270.00 to $270.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 18, 2013 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Peter Powchik
2013-12-20